Health Policy Check Up News

Biosimilars: Price, Policy and Outlook

We would like to thank the National Association of Specialty Pharmacy (NASP) for allowing us to present at this year’s Annual Meeting.

Our presentation, Biosimilars: Price, Policy and Outlook, had the following objectives:

  • Identify the definition of biosimilars
  • Outline the difference between biosimilars and generics
  • Describe the FDA’s outlook on biosimilars
  • Explain the supportive policy environment being put into place for biosimilars
  • Discuss the outlook for biosimilars as interchangeability policies and legislation evolves

For more information regarding Biosimilars, contact us today.